|
Home : Unsafe Drugs : Avandia : Newsfeeds : EARNINGS PREVIEW: GlaxoSmithKline 1Q Net Profit Seen Down 1.3% EARNINGS PREVIEW: GlaxoSmithKline 1Q Net Profit Seen Down 1.3%
Lower Avandia, Valtrex and Advair sales will also have had an impact. However earnings will have got some support from the disposal of the stake in Quest Diagnostics in February.
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




